rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
12
|
pubmed:dateCreated |
2010-12-1
|
pubmed:abstractText |
Vancomycin alternatives, including clindamycin, have in vitro activity against current strains of methicillin-resistant Staphylococcus aureus (MRSA), but clinical evidence of their effectiveness is needed.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Nov
|
pubmed:issn |
1879-114X
|
pubmed:author |
|
pubmed:issnType |
Electronic
|
pubmed:volume |
32
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
2024-9
|
pubmed:meshHeading |
pubmed-meshheading:21118737-Adult,
pubmed-meshheading:21118737-Anti-Bacterial Agents,
pubmed-meshheading:21118737-Clindamycin,
pubmed-meshheading:21118737-Hospitals, University,
pubmed-meshheading:21118737-Humans,
pubmed-meshheading:21118737-Inpatients,
pubmed-meshheading:21118737-Male,
pubmed-meshheading:21118737-Methicillin-Resistant Staphylococcus aureus,
pubmed-meshheading:21118737-Middle Aged,
pubmed-meshheading:21118737-Retrospective Studies,
pubmed-meshheading:21118737-Staphylococcal Skin Infections,
pubmed-meshheading:21118737-Vancomycin
|
pubmed:year |
2010
|
pubmed:articleTitle |
Retrospective cohort study of hospitalized adults treated with vancomycin or clindamycin for methicillin-resistant Staphylococcus aureus skin infections.
|
pubmed:affiliation |
College of Pharmacy, University of Texas at Austin, Austin, Texas 78229-3900, USA. freic@uthscsa.edu
|
pubmed:publicationType |
Journal Article,
Comparative Study,
Research Support, Non-U.S. Gov't
|